Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case

We present two Delta (B.1.617.2) vaccine breakthrough individuals, a father and son living in separate households. The older, 63-year-old patient's symptoms were severe enough to require hospitalization. Despite having a high titer of anti-spike IgG in his serum, his symptoms resolved within 24...

Descripción completa

Detalles Bibliográficos
Autores principales: Connor, Bradley A, Couto-Rodriguez, Mara, Barrows, Joseph E, Gardner, Morgan, Rogova, Marina, O'Hara, Niamh B., Nagy-Szakal, Dorottya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276551/
https://www.ncbi.nlm.nih.gov/pubmed/34271202
http://dx.doi.org/10.1016/j.ijid.2021.07.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276551/
https://www.ncbi.nlm.nih.gov/pubmed/34271202
http://dx.doi.org/10.1016/j.ijid.2021.07.029

Ejemplares similares